God Quest, Inc. d/b/a Creation Today
Letter data
- Company
- God Quest, Inc. d/b/a Creation Today
- Recipient
- God Quest, Inc. d/b/a Creation Today | United States
- Issue date
- 2018-03-05
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 522709
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
God Quest, Inc. d/b/a Creation Today
MARCS-CMS 522709 —
March 05, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
God Quest, Inc. d/b/a Creation Today
United States
Issuing Office:
United States
Office of Regulatory Affairs
Office of Human and Animal Food Operations
East Division IV
Compliance Branch
466 Avenida Fernández Juncos
San Juan, Puerto Rico 00901-3223
Tel:
(787) 729-8500
Office of Regulatory Affairs
Office of Human and Animal Food Operations
East Division IV
Compliance Branch
466 Avenida Fernández Juncos
San Juan, Puerto Rico 00901-3223
Tel:
(787) 729-8500
March 5, 2018
18-HAFE4-WLCOL-03
VIA UNITED PARCEL SERVICE
NEXT DAY - SIGNATURE REQUIRED
Mr. Eric M. Hovind, President
God Quest, Inc. d/b/a Creation Today
29 Cummings Road
Pensacola, FL 32503
Re: Warning Letter, 17-OHAFOED4-WL-06/CMS No.522709 dated 06/29/2017
Dear Mr. Hovind:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter, 17-OHAFOED4-WL-06/CMS No.522709 dated 06/29/2017. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Kind regards,
/S/
Edwin Ramos
Director of Compliance Branch
OHAFO East Division IV
Content current as of:
03/07/2018